Evidence map›Paper›PMID 11556842›Full record

ArticleBritish journal of cancer2001

Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours.

C Scotton, D Milliken, J Wilson, S Raju, F Balkwill

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Anti-Inflammatory Drugs as Anticancer Agents.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Cancer-related inflammation.Journal of clinical immunology · 2013
    Review
  20. Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C ScottonICRF Translational Oncology Laboratory, St Bartholomew's and Royal London School of Medicine and Dentistry, Science Building, Charterhouse Square, London EC1M 6BQ, UK.
D Milliken
J Wilson
S Raju
F Balkwill
St Thomas' Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To understand the chemokine network in a tissue, both chemokine and chemokine receptor expression should be studied. Human epithelial ovarian tumours express a range of chemokines but little is known about the expression and localisation of chemokine receptors. With the aim of understanding chemokine action in this cancer, we investigated receptors for CC-chemokines and their ligands in 25 biopsies of human ovarian cancer. CC-chemokine receptor mRNA was generally absent from solid tumours, the exception being CCR1 which was detected in samples from 75% of patients. CCR1 mRNA localised to macrophages and lymphocytes and there was a correlation between numbers of CD8(+) and CCR1 expressing cells (P = 0.031). mRNA for 6 CC-chemokines was expressed in a majority of tumour samples. In a monocytic cell line in vitro, we found that CCR1 mRNA expression was increased 5-fold by hypoxia. We suggest that the CC-chemokine network in ovarian cancer is controlled at the level of CC-chemokine receptors and this may account for the phenotypes of infiltrating cells found in these tumours. The leukocyte infiltrate may contribute to tumour growth and spread by providing growth survival factors and matrix metalloproteases. Thus, CCR1 may be a novel therapeutic target in ovarian cancer.

Indexed as

Adenocarcinoma, Clear CellBase SequenceBlotting, NorthernCarcinomaCarcinoma, Signet Ring CellCD8-Positive T-LymphocytesChemokines, CCCystadenocarcinoma, SerousEndometrial NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansImmunoenzyme TechniquesIn Situ HybridizationMolecular Sequence DataOvarian NeoplasmsCCR1 protein, humanChemokines, CCReceptors, CCR1Receptors, ChemokineRibonucleasesRNA, Messenger

Identifiers

PMID11556842
PMCPMC2375063
OpenAlexW1974634396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.